PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Pfizer
Pfizer
Takeda
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Sanofi
Pfizer
NuCana plc
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Hutchmed
Mayo Clinic
Seagen Inc.
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Inhibrx Biosciences, Inc
ADC Therapeutics S.A.
University of Florida
Fusion Pharmaceuticals Inc.
pharmaand GmbH
Fate Therapeutics
Genmab
Silverback Therapeutics
Incyte Corporation
Seagen Inc.
KitovPharma
AIDS Malignancy Consortium
CureOne
Cornerstone Pharmaceuticals
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
Auron Healthcare GmbH
National Cancer Institute (NCI)
Massachusetts General Hospital
Cancer Research UK